Correction to: Photoactivatable Silencing Extracellular Vesicle (PASEV) Sensitizes Cancer Immunotherapy (Advanced Materials, (2022), 34, 35, 10.1002/adma.202204765)

Mei Lu, Haonan Xing, Wanxuan Shao, Tian Zhang, Mengjie Zhang, Yongchao Wang, Fangzhou Li, Yuhua Weng, Aiping Zheng, Yuanyu Huang, Xing Jie Liang

科研成果: 期刊稿件评论/辩论

摘要

Adv. Mater. 2022, 34, 2204765 DOI: 10.1002/adma.202204765 The H&E image of the PASsiNCEV L+ group in Figure 5f and the immunofluorescent images of HMGB1 in the PBS and PASsiNCEV L+ groups in Figure S19c (Supporting Information) were used in error. The authors identified the mistake, and the corrected Figures 5f and S19c (Supporting Information) are as follows: Figure 5f. Representative images for hematoxylin and eosin (H&E) staining, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and Ki67 assay of the excised tumors. Scale bar: 100 µm. Figure S19c. Immunofluorescence imaging and quantitative analysis of CRT exposure and HMGB1 release in the primary tumor tissues of CT26-Luc tumor-bearing mice. Blue, cell nuclei. Red, CRT (the upper rows), and HMGB1 (the lower rows). Scale bar, 100 µm. Statistical significance was performed by one-way ANOVA with a Tukey post hoc test. *p < 0.05, **p < 0.01, ****p < 0.0001. We apologize for the error. The correction does not affect the conclusion drawn from the paper.

源语言英语
文章编号2505455
期刊Advanced Materials
37
24
DOI
出版状态已出版 - 19 6月 2025

指纹

探究 'Correction to: Photoactivatable Silencing Extracellular Vesicle (PASEV) Sensitizes Cancer Immunotherapy (Advanced Materials, (2022), 34, 35, 10.1002/adma.202204765)' 的科研主题。它们共同构成独一无二的指纹。

引用此